News
Key to more effective vaccines revealed
Researchers from the Centenary Institute and the University of Sydney have made a major discovery in vaccine science, gaining new insights into delta inulin as a crucial vaccine component. Their findings offer a promising pathway for advancing the next generation of vaccines.
-
Support for state-of-the-art cancer research projects
The Centenary Institute has received important funding from the RT Hall Trust to bolster two ground-breaking cancer research initiatives. Almost one in two Australians will be diagnosed with cancer by the age of 85. Cancer is a leading cause of death, claiming around 50,000 Australians annually.News Type: Media releaseDate
-
Associate Professor Guy Lyons honoured with award
Associate Professor Guy Lyons, a Laboratory Head at the Centenary Institute’s Centre for Cancer Innovations, has been awarded the prestigious Barry Preston Award by the Matrix Biology Society of Australia & New Zealand.News Type: Research NewsDate
-
Revealing the role of immune cells in liver cancer
New research from the Centenary Institute and the University of Sydney has uncovered important insights into the immune environment within liver cancer, the sixth most common cancer worldwide and the third leading cause of cancer-related deaths.News Type: Media releaseDate
-
Research award to advance breast cancer treatments
Dr Mark Schreuder, a researcher at the Centenary Institute’s Centre for Cancer Innovations, has received the Kenyon Foundation Inflammation Award for 2024.News Type: Media releaseDate
-
Research grant awarded to study resistant melanoma
Dr Jessamy Tiffen, Head of the Centre for Cancer Innovations at the Centenary Institute, and her master’s student Laura Nicholls, have been awarded a $10,000 research grant from the Australian Melanoma Research Foundation.News Type: Research NewsDate
-
Advancing melanoma treatment against resistance
Research conducted by the Centenary Institute has revealed a promising new approach to tackling melanoma, an aggressive form of skin cancer notorious for its resistance to conventional treatments.News Type: Media releaseDate
-
Research grant to advance ovarian cancer treatment
The Centenary Institute has received vital grant funding from Cancer Australia to lead new research efforts targeting chemotherapy resistance in ovarian cancer patients.News Type: Media releaseDate
-
Tour de Cure funding to boost cancer research at the Centenary Institute
Three Centenary Institute scientists have been awarded grants totalling $150,000 from the Tour de Cure cancer research funding scheme.News Type: Research NewsDate
-
New technology, ‘Invasion-Block’, targets melanoma spread
Research conducted at the Centenary Institute has given rise to a ground-breaking tool called 'Invasion-Block' that can identify drugs capable of halting the spread of cancer cells. The pioneering development could lead to better treatments for melanoma, the most dangerous form of skin cancer.News Type: Media releaseDate
-
New treatment offers hope for advanced liver cancer
Researchers have discovered a new way to treat hepatocellular carcinoma (HCC), the most common type of liver cancer and the third leading cause of cancer death worldwide.News Type: Media releaseDate
-
Dr Tiffen provides insight at leadership event
Dr Jessamy Tiffen, Head of the Centenary Institute’s Epigenetics of Melanoma Program, has been an invited panel guest at a special leadership event hosted by the law firm Jones Day.News Type: EventsDate
-
New study uncovers potential therapeutic target for breast cancer
Research conducted at the Centenary Institute has unveiled crucial insights into the underlying molecular mechanisms of breast cancer. The findings could lead to a more effective treatment for the disease, which claims the lives of over 3,000 Australian women and men annually.News Type: Media releaseDate